Sign in
Biotech
Medtech
Pharma
Public Health
Real Estate
Events
Home
Sign in
Welcome!
Log into your account
your username
your password
Forgot your password?
Password recovery
Recover your password
your email
Search
Sunday, October 25, 2026
Advertising
About Us
Subscribe to Newsletter
Facebook
X
Youtube
Biotech
Medtech
Pharma
Public Health
Real Estate
Events
Home
Search
Home
Venture Capital
Venture Capital
Venture Capital
Estuary Biotherapeutics Launches with $103 Million to Advance Gene Therapies for Kidney Disease
Life Sciences Times
-
October 16, 2026
Venture Capital
Acta Pharmaceuticals Raises $24 Million to Advance Alzheimer’s Disease Treatments
Life Sciences Times
-
October 15, 2026
Venture Capital
Soufflé Therapeutics Raises $135 Million in Series B Financing to Advance RNA Therapies
Life Sciences Times
-
October 13, 2026
Venture Capital
Consano Bio Raises More Than $15 Million to Advance Chronic Sciatica Therapy
Life Sciences Times
-
October 5, 2026
Venture Capital
ai3Bio Launches With $48 Million Series A to Advance Autoimmune Disease Therapies
Life Sciences Times
-
September 29, 2026
Venture Capital
Jeito Capital Co-Leads $76 Million Series A Financing for CDR-Life, its 10th Investment Since its Launch
Life Sciences Times
-
April 13, 2022
0
Venture Capital
Sampling Human Raises $2 Million to Support the Development of Engineered Cells for Single Cell Analysis
Life Sciences Times
-
April 13, 2022
0
Venture Capital
Aurion Biotech Raises $120 Million from Deerfield Management, Petrichor, Flying L Partners, Falcon Vision/KKR, and Visionary Ventures
Life Sciences Times
-
April 12, 2022
0
Venture Capital
Design Pharmaceuticals Closes $5 Million Pre-series A Round to Accelerate Commercialization of Ultrahigh Throughput Drug Discovery Platform
Life Sciences Times
-
April 12, 2022
0
Venture Capital
PhableCare Raises $25 M in Series B Funding
Life Sciences Times
-
April 11, 2022
0
Venture Capital
Ansa Biotechnologies Closes Oversubscribed $68 Million Series A Financing to Power the Next Era of DNA-Enabled Industries
Life Sciences Times
-
April 11, 2022
0
Venture Capital
I-VASC Srl Announces achievement of 1,8M € Series A investment to launch its product, VELEX™, a device for the treatment of Chronic Venous Insufficiency...
Life Sciences Times
-
April 8, 2022
0
Venture Capital
Andera Partners to sell its Life Sciences’ portfolio company ReViral to Pfizer
Life Sciences Times
-
April 7, 2022
0
Venture Capital
Receptor Life Sciences Secures $9.7 Million Financing to Advance RLS103 (Inhaled Dry Powder CBD) into Clinical Trials
Life Sciences Times
-
April 7, 2022
0
Venture Capital
Codetta Biosciences Announces $15 Million in Series A Financing
Life Sciences Times
-
April 7, 2022
0
Venture Capital
Clarify Health Closes $150M Series D Funding to Unlock the Promise of Value-Based Care with End-to-End Intelligence on Every Patient Journey
Life Sciences Times
-
April 5, 2022
0
Venture Capital
Bruker Acquires Optimal Companies for Pharma PAT Software and Biopharma Manufacturing Automation Expertise and Technologies
Life Sciences Times
-
April 5, 2022
0
1
...
79
80
81
...
115
Page 80 of 115
Most Read
Alnylam Reports Promising Phase 1b Results for Experimental Huntington’s Disease Treatment
October 23, 2026
Zai Lab Reports Promising Early Results for Experimental Small Cell Lung Cancer Treatment
October 23, 2026
Takeda Reports Improved Survival in Phase 3 Trial of Experimental Gastric Cancer Treatment
October 23, 2026
Convergent Therapeutics Reports Promising Phase 2 Results for Prostate Cancer Treatment
October 23, 2026